Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesEntourage Health Corp

Entourage Health Corp

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.005 CAD 0.00(0%)
Last update at 2025-04-08T13:30:00Z
VOLUME
445000
Market Cap
3.08M

Momentum Score

…

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary's Medicinals, and Royal City Cannabis brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.01
Low
0.01
High
52 Week Price Range
0.01
Low
0.02
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
40.67M
Revenue Per Share
0.13
Gross Profit TTM
-11.71M
Debt / Equity
-
ROE
-371.10%
Net Debt
149.75M
ROCE
36.55%
Diluted EPS TTM
-0.14

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -123.15M -78.94M -89.61M -10.39M -0.90M
Net income -123.15M -78.94M -89.61M -10.39M -0.90M
Selling general administrative 29.64M 29.19M 28.48M 21.06M 14.92M
Gross profit -19.89M -11.71M -24.21M 14.87M 4.63M
Reconciled depreciation 5.85M 6.75M 2.15M 0.28M 0.10M
Ebit -51.51M -44.04M -56.64M -8.36M -10.53M
Ebitda -100.10M -61.41M -81.55M -8.87M -0.35M
Operating income -52.03M -41.74M -51.46M -6.51M -10.34M
Interest expense 17.19M 10.77M 5.91M 1.24M 0.44M
Tax provision 0.00M - - - 0.00M
Interest income - 0.00M 0.07M 0.22M 0.51M
Net interest income -17.46M -10.89M -5.84M -1.02M 0.07M
Total revenue 40.89M 42.27M 29.43M 20.82M 7.96M
Total operating expenses 92.92M 84.01M 80.89M 27.33M 18.29M
Cost of revenue 60.78M 53.99M 53.64M 5.95M 3.32M
Total other income expense net -53.66M -26.31M -32.31M -2.86M 9.37M
Net income from continuing ops -123.15M -78.94M -89.61M -10.39M -0.90M
Net income applicable to common shares - -78.94M -89.61M -10.39M -0.90M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 31.39M 46.47M 144.22M 171.33M 209.80M
Intangible assets - - - 4.50M 21.00M
Other current assets - - 0.71M 8.10M 10.78M
Total liab 178.69M 147.71M 122.80M 97.24M 73.74M
Total stockholder equity -147.29M -101.24M 21.43M 74.09M 136.06M
Other current liab - - - 0.80M 2.69M
Common stock - - 185.81M 163.23M 137.65M
Capital stock 186.23M 186.14M 185.81M 163.23M 137.65M
Retained earnings -365.54M -319.37M -196.22M -117.29M -27.68M
Other liab - - - - 0.13M
Good will - - - - 16.12M
Other assets - - 1.10M 0.49M 0.82M
Cash 11.15M 9.08M 21.42M 22.32M 8.18M
Total current liabilities 172.31M 141.88M 116.39M 21.73M 29.15M
Net debt 149.75M 124.50M 81.00M 55.98M 35.97M
Short long term debt 155.11M 128.42M 97.85M 3.99M 1.87M
Other stockholder equity - - 14.97M 12.11M 12.11M
Property plant equipment - - 81.70M 100.04M 112.09M
Total current assets 25.41M 40.09M 61.43M 66.30M 59.77M
Net tangible assets - - 21.43M 69.59M 98.94M
Short term investments - - 0.00M 0.23M 0.44M
Net receivables 2.92M 3.79M 8.73M 4.20M 6.13M
Long term debt 5.79M 5.15M 4.57M 74.32M 42.28M
Inventory 10.01M 14.78M 29.64M 30.67M 31.29M
Accounts payable 1.96M 2.67M 5.12M 7.62M 23.13M
Non current assets total 5.99M 6.38M 82.84M 104.54M 150.03M
Capital lease obligations 0.68M 0.96M 2.94M 2.57M 3.65M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1.32M 1.84M 0.14M 0.52M -1.27M
Change to liabilities - 0.00M 0.00M 14.60M -0.24M
Total cashflows from investing activities - 1.84M -1.40M -48.96M -28.92M
Net borrowings - 11.10M 29.26M 47.47M 47.47M
Total cash from financing activities 21.14M 24.06M 51.26M 46.09M 34.99M
Change to operating activities - -18.22M -27.25M 4.92M 1.44M
Net income -123.15M -78.94M -89.61M -10.39M -0.90M
Change in cash -10.34M -4.10M 14.32M -10.03M -3.37M
Begin period cash flow 21.52M 25.62M 11.30M 21.32M 24.70M
End period cash flow 11.18M 21.52M 25.62M 11.30M 21.32M
Total cash from operating activities -30.17M -30.01M -35.54M -7.16M -9.44M
Issuance of capital stock 0.00M 15.58M 25.00M 0.00M 32.22M
Depreciation 5.85M 6.75M 7.00M 1.11M 0.10M
Other cashflows from investing activities - - - -2.24M 8.83M
Dividends paid 0.00M 0.00M 0.00M 0.00M 0.00M
Change to inventory -8.23M -11.46M 11.98M -13.99M -2.94M
Change to account receivables 3.65M -4.58M 1.09M -1.31M -2.07M
Other cashflows from financing activities - -2.87M -3.00M -1.91M 2.38M
Change to netincome - 60.39M 74.31M -2.09M -4.84M
Capital expenditures 1.70M 0.45M 1.18M 55.29M 36.48M
Change in working capital -10.42M -18.22M 4.87M 4.21M -3.81M
Stock based compensation 0.48M 0.86M 2.64M 4.76M -
Other non cash items 27.36M 18.92M 8.12M -8.87M -1.38M
Free cash flow -31.86M -30.51M -37.08M -63.65M -37.09M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ENTG
Entourage Health Corp		 -
-%		 0.01 - - 0.08 2.69 4.31 -2.22
RX
Biosyent Inc.		 0.30
1.78%		 17.15 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 0.21
11.67%		 2.01 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 0.03
9.38%		 0.35 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.		 0.01
1.64%		 0.31 20.75 - 1.88 1.89 2.85 10.19

Profile*

Entourage Health Corp

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary's Medicinals, and Royal City Cannabis brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.

250 Elm Street, Aylmer, ON, Canada, N5H 2M8

844 933 3636

https://entouragehealthcorp.com

Name Title Year Born
Mr. George Scorsis Exec. Chair & CEO 1976
Ms. Deborah Sikkema Chief People Officer NA
Mr. Jeff Keyes Sr. VP of Operations NA
Mr. Joseph Mele Chief Commercial Officer NA
Ms. Vaani Maharaj Chief Financial Officer NA
Mr. James Afara Chief Operating Officer NA
Dr. Alexandre Sibilev Vice-Pres of Quality Assurance & Global Regulatory Compliance NA
Ms. Marianella delaBarrera Sr. VP of Communications & Corp. Affairs NA
Mr. Michael P. Kraft Strategic Advisor to the board 1963
Dr. Jonas Vanderzwan Medical Director & Chair of Clinical Advisory Board NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.34
+14.45%
OMG
CAD 1.70
+13.76%
ARTG
CAD 39.54
+12.59%
DSV
CAD 10.83
+12.58%
TLRY
CAD 4.17
+12.10%
DRUG
CAD 25.95
-30.02%
HUT
CAD 69.16
-22.20%
UCU
CAD 2.04
-16.39%
PHX
CAD 10.70
-15.62%
VET
CAD 15.04
-13.31%

Equity Sectors*

  • Basic Materials

    +4.80%

  • Communication Services

    +2.78%

  • Consumer Cyclical

    +2.82%

  • Consumer Defensive

    +0.74%

  • Energy

    -4.92%

  • Financial Services

    +2.47%

  • Healthcare

    -0.30%

  • Industrials

    -0.38%

  • Real Estate

    +1.75%

  • Technology

    +0.82%

  • Utilities

    +1.29%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…